{"id":"W7033626156","doi":"","title":"Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer","year":2018,"lang":"en","type":"review","venue":"Dove Medical Press (Taylor and Francis Group)","topic":"Education, Innovation and Language Studies","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"PARP inhibitor; Ovarian cancer; Loss of heterozygosity; Poly ADP ribose polymerase; Clinical trial; Cancer; DNA repair; Adverse effect; Olaparib","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001528759,0.0004936375,0.0004776531,0.0003854833,0.0002278234,0.0004689928,0.0006837471,0.0005689443,0.005408439],"category_scores_gemma":[0.0001155727,0.0001583455,0.0003011522,0.0004107728,0.0002327428,0.000277609,0.0003059941,0.001342283,0.001757215],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005869743,"about_ca_system_score_gemma":0.0004870108,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007424785,"about_ca_topic_score_gemma":0.00148385,"domain_scores_codex":[0.9999331,0.0000098094,0.000004865118,0.00001512327,0.00001856239,0.00001843846],"domain_scores_gemma":[0.9999398,0.000004990061,0.00001054996,0.000004918032,0.000009868137,0.00002974615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005534615,0.002905423,0.002527262,0.001499413,0.0002188563,0.002312416,0.0001180609,0.002353668,0.4453367,0.002494988,0.04615829,0.4885404],"study_design_scores_gemma":[0.01152069,0.02206265,0.02672463,0.0003335008,0.0004693069,0.02583152,0.00008844101,0.01005105,0.4175845,0.0008463873,0.484347,0.0001401951],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.6838837,0.2310915,0.012807,0.004971134,0.001294965,0.00135348,0.004548193,0.002831467,0.05721864],"genre_scores_gemma":[0.8997975,0.05468795,0.008051383,0.001923598,0.0003731296,0.000530144,0.00772049,0.0001091987,0.02680651],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.005408439,"threshold_uncertainty_score":0.01809305,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1208211951815161,"score_gpt":0.4317151893169112,"score_spread":0.310893994135395,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}